Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
111 studies found for:    telaprevir
Show Display Options
Rank Status Study
1 Completed A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment
Condition: Hepatic Impairment
Intervention: Drug: telaprevir
2 Completed Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects
Conditions: Hepatitis C;   Chronic Hepatitis C
Interventions: Drug: Miravirsen sodium;   Drug: Telaprevir
3 Completed A Study to Investigate the Potential Interaction Between Telaprevir and Methadone, at Steady-State
Condition: Healthy Participants
Interventions: Drug: Telaprevir;   Drug: Methadone
4 Completed
Has Results
A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Telaprevir;   Drug: Peg-IFN-alfa-2a + Ribavirin (Standard Treatment);   Drug: Placebo
5 Completed VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.
Conditions: Hepatitis C;   Telaprevir;   HIV
Intervention: Drug: Telaprevir; Darunavir; Ritonavir; Fosamprenavir
6 Completed Virology Follow up Study in Subjects Previously Treated With Telaprevir
Condition: Hepatitis C
Intervention: Drug: telaprevir
7 Completed
Has Results
Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1
Condition: Hepatitis C, Chronic
Intervention: Drug: Telaprevir and Sofosbuvir
8 Terminated Interaction Between Paroxetine and Telaprevir
Conditions: Hepatitis C Infection;   Depression
Interventions: Drug: Paroxetine;   Drug: telaprevir
9 Completed Telaprevir Open-Label Study in Co-Infected Patients
Condition: Hepatitis C, Chronic
Intervention: Drug: Telaprevir
10 Completed Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Telaprevir;   Biological: pegIFN alfa-2a;   Drug: Ribavirin
11 Completed VX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir.
Conditions: Hepatitis C;   Kidney Diseases
Intervention: Drug: telaprevir
12 Terminated
Has Results
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
Condition: Infection
Interventions: Drug: Pegylated Interferon Alfa 2a;   Drug: Ribavirin;   Drug: Telaprevir
13 Completed
Has Results
VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo
Condition: Hepatitis C, Chronic
Interventions: Drug: Telaprevir;   Drug: pegylated interferon (Peg-IFN) alfa-2a;   Drug: ribavirin (RBV)
14 Completed A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects
Condition: Chronic Hepatitis C
Interventions: Drug: telaprevir formulation A;   Drug: telaprevir Formulation B;   Drug: telaprevir Formulation C;   Drug: telaprevir Formulation D
15 Completed
Has Results
An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection
Condition: Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Pegylated-interferon-alfa-2a;   Drug: Placebo;   Drug: Ribavirin
16 Terminated
Has Results
Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C
Condition: Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Ribavirin;   Biological: Pegylated Interferon Alfa-2a
17 Withdrawn Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1
Condition: Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin;   Dietary Supplement: Vitamin D
18 Completed An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation
Condition: Chronic Hepatitis C Virus (HCV) Infection
Interventions: Drug: Telaprevir;   Drug: Pegylated interferon alfa-2a;   Drug: Ribavirin
19 Completed VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir
Condition: Hepatitis C
Interventions: Drug: Treatment sequence AB;   Drug: Treatment sequence BA
20 Completed Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Ritonavir withdrawal, atazanavir 200 mg/12h;   Drug: Telaprevir interactions

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.